Business
BioLife Solutions Signs Multi-Year Supply Agreement with Qkine Limited to Expand its Product Portfolio into the Rapidly Growing Cytokines Market
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces it has entered into a multi-year supply agreement with Qkine Limited under which BioLife will distribute certain cytokine and growth factor products manufactured by Qkine for use in cell and gene therapy manufacturing.
About this update from Biolife Solutions, Inc.
[{"type":"text","content":"BOTHELL, Wash., Feb. 12, 2026 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces it has entered into a multi-year supply agreement with Qkine Limited under which BioLife will distribute certain cytokine and growth factor products manufactured by Qkine for use in cell and gene therapy manufacturing.","length":432,"tagName":"p"},{"type":"image","alt":"BioLife Solutions Logo (PRNewsfoto/BioLife Solutions, Inc.)","displaySize":"","headline":null,"caption":"BioLife Solutions Logo (PRNewsfoto/BioLife Solutions, Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":111,"url":"https://media.zenfs.com/en/prnewswire.com/2c77b8327844a4e269c45c61c477e453"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/dk9sWRfYQGFiZfYvs0ludw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE5NjtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/2c77b8327844a4e269c45c61c477e453","width":400,"height":111}},"href":"https://mma.prnewswire.com/media/2827727/BioLife_Solutions__Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The agreement provides BioLife with exclusive worldwide distribution rights to specific Qkine products for the CGT market and non-exclusive rights to Qkine products in the CGT market. In addition, the companies intend to collaborate on a process development and validation program to enable Qkine to package certain of its products using BioLife's proprietary CellSeal® Connect vial system, which is designed to be incorporated into closed system and/or automated CGT workflows.","length":482,"tagName":"p"},{"type":"text","content":"Roderick de Greef, BioLife's Chairman and CEO, commented, "We are pleased to establish this strategic distribution and CellSeal® Connect product development relationship with Qkine, a recognized leader in the fast-growing cytokines market. Qkine's cytokine products are highly complementary to our cell culture supplement offerings and expand the portfolio of solutions we offer our CGT customers. We have specifically identified cytokines along with other biologically active cell culture media components as attractive, fast-growing and profitable adjacent product categories that align with our long-term growth strategy....